Infectious diseases and vaccines Archives - Page 8 of 11

The economic burden of bronchiectasis – known and unknown: a systematic review

Authors: P C Goeminne, F Hernandez, R Diel, A Filonenko, R Hughes, F Juelich, G M Solomon, A Upton, K Wichmann, W Xu, J D Chalmers Published: BMC Pulmonary Medicine, 2019 View...

Long-Term Assessment of Healthcare Utilization Five Years After Respiratory Syncytial Virus Infection in US Infants

Authors: VV Chirikov, EAF Simões EAF, M Botteman, A Kuznik, Y Kwon, Published: The Journal of Infectious Diseases, 2019 View publication BACKGROUND Respiratory syncytial virus (RSV) is the primary cause of respiratory...

Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: A systematic review and network meta-analysis

Authors: S J Snedecor, M Radford, D Kratochvil, R Grove, Y S Punekar Published: BMC Infectious diseases, 2019 View publication Background Network meta-analyses (NMAs) provide comparative treatment effects estimates in the absence...

Early switch/early discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Brazil

Authors: G H Furtado, J Rocha, R Hayden, C Solem, C Macahilig, W Tang, R Chambers, M L N Figueiredo, C Johnson, J Stephens, S Haider Published: The Brazilian Journal of Infectious...

Treatment of immunocompromised patients with suspected invasive fungal infections: economic analysis of diagnostic-driven versus empirical strategies in Algeria and Egypt

Authors: Z Kaci, L Shalaby, S Kamal, N Boudjerra, X Gao, M Xue, S Ait Belkacem, A Gab Allah Ibrahim, R Kotb, C Charbonneau Published: Expert Review of Pharmacoeconomics & Outcomes Research,...

Economic-Burden Trajectories in Commercially Insured US Infants with Respiratory Syncytial Virus.

Authors: VV Chirikov, EAF Simões EAF, A Kuznik, Y Kwon, M Botteman Published: The Journal of infectious diseases, 2019 View publication Economic Burden Trajectories in Commercially Insured US Infants with Respiratory Syncytial...

Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico

Authors: R Morfin-Otero, M Alvarado-Ibarra, E Roderiquez-Noriega, J Resendiz-Sanchez, D A Patel, J M Stephens, M Di Fusco, C F Mendoza, C Charbonneau Published: ClinicoEconomics and Outcomes Research, 2018 View publication Background...

Development of a comprehensive dataset of hepatitis C Patients and examination of disease epidemiology in the United States, 2013-2016

Authors: V V Chirikov, S E Marx, S R Manthena, J P Strezewski, S Saab Published: Advances in Therapy, 2018 View publication Introduction Chronic infection with hepatitis C virus (HCV) is a...

Cost-effectiveness of atazanavir/ritonavir compared with lopinavir/ritonavir in treatment-naïve human immunodeficiency virus-1 patients in Sweden

Authors: P O Thuresson, B Heeg, B Lescrauwaet, K Sennfält, A Alaeus, A Neubauer Published: Scandinavian Journal of Infectious Diseases, 2011 View publication Objective The aim of this study was to estimate...

News